HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veronica Bunn Selected Research

mobocertinib

12/2021Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial.
1/2021Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veronica Bunn Research Topics

Disease

2Mycosis Fungoides
12/2021 - 01/2021
2Peripheral Nervous System Diseases (PNS Diseases)
12/2021 - 01/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 01/2021
1Lymphoma (Lymphomas)
10/2022
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2022
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2022
1Primary Cutaneous Anaplastic Large Cell Lymphoma
12/2021
1Pain (Aches)
12/2021
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
12/2021
1Pruritus (Itching)
12/2021
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2020
1Neoplasms (Cancer)
01/2020

Drug/Important Bio-Agent (IBA)

3Brentuximab VedotinIBA
12/2021 - 01/2020
2Methotrexate (Mexate)FDA LinkGeneric
12/2021 - 01/2020
2Bexarotene (LGD1069)FDA Link
12/2021 - 01/2020
2mobocertinibIBA
12/2021 - 01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022
1Prednisone (Sone)FDA LinkGeneric
10/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022
1Vincristine (Oncovin)FDA LinkGeneric
10/2022
1PlatinumIBA
12/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021

Therapy/Procedure

2Therapeutics
10/2022 - 01/2020